SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Morgan Stanleys designation of Amazon as a top pick, alongside optimism about AWS growth and AI initiatives such as Trainium, is driving attention. Many traders welcomed the sharp move, while others questioned the rally or discussed taking profits and looking for a pullback.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine shares are surging after bitopertin met all primary and secondary endpoints in the Phase 3 APOLLO trial for erythropoietic protoporphyria, strengthening the case for an FDA resubmission, though approval remains ahead and dizziness incidence has drawn some concern. Traders are broadly bullish on the trial result, with discussion also focused on short-covering and whether the rally can hold.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are drawing attention after a sharp selloff and break below technical support, with traders pointing to disclosed insider selling and a DBS downgrade as possible pressures. The community is divided between expecting further declines and viewing the pullback as a buying opportunity, while some also cite weakness in Indonesian markets and broader regional macro concerns.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs stronger-than-guided third-quarter results and upbeat 2027 EBITDA outlook have driven a sharp rally, with traders also pointing to short-covering and higher steel prices. The reaction is divided: bulls see room for continued gains, while skeptics warn the rally could fade and question whether the outlook can overcome the companys debt concerns.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRX is drawing attention for a sharp selloff despite the FDAs expanded ANKTIVA approval for papillary bladder cancer and encouraging long-term trial data. Traders debate whether the decline reflects sell-the-news profit-taking and broader biotech weakness, while others blame options-related pressure or short selling; concerns about revenue growth and future dilution also surface.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention after a steep post-IPO selloff, with traders citing share-unlock and insider-selling pressure, valuation and growth concerns, and broader weakness in AI and semiconductor stocks. Bulls are buying the dip and arguing the decline is overdone, while bears warn that selling could continue.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunruns continued share-price decline and heavy short interest dominate the discussion, with traders debating whether rate-sensitive solar-sector pressures and weak guidance outweigh the companys storage, virtual-power-plant, and AI data-center potential. Some see a possible short squeeze or recovery, while others expect further downside.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

Almonty is drawing attention after a sharp selloff around its investor day, with traders divided over CEO Lewis Blacks presentation: some found the remarks positive, while others read his delivery as a sign of undisclosed problems. Bullish holders continue to cite the Sangdong production ramp and tungsten-supply outlook, while skeptics are focused on execution and the lack of clear reassurance.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgrade of CoreWeave to Buy after a sharp selloff sparked a rebound attempt, but traders debated whether the call could overcome persistent selling. The main divide is between optimism about AI-compute demand and contracted backlog, and concern that heavy debt and financing costs could threaten the business.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

FDA clearance to expand Alpha Taus U.S. recurrent glioblastoma REGAIN trial is driving attention, alongside anticipated clinical data at the SNO meeting. Traders are encouraged by the early results but are also looking ahead to confirmation in a larger cohort; completion of enrollment in the pancreatic cancer IMPACT study adds to the pipeline-catalyst discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should iShares Morningstar Small-Cap Value ETF (ISCV) Be on Your Investing Radar?

This Stock That's Up Over 8X In A Year Is Not Too Expensive Yet, According To One Analyst

Equity

Analysts at Citizens initiated coverage of Keel Infrastructure with an ‘Outperform’ rating and a price target of $10, implying an upside potential of 46% from current levels.

iShares Trust - iShares Morningstar Small-Cap Value ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Citizens said Keel is capitalizing on a broader industry shift in which former bitcoin mining operators are repurposing existing power infrastructure to serve artificial intelligence and high-performance computing workloads.</li><li>The firm noted that Keel's access to power capacity positions it to benefit from growing demand from hyperscale customers.</li><li>Citizens believes Keel is benefiting from the same market dynamics that have driven substantial outperformance among many of its peers over the past year.</li></ul>Shares of Keel Infrastructure Corp. (KEEL) are up more than 177% year-to-date, and Wall Street thinks the surge in the company’s shares is not done yet.According to TheFly, analysts at Citizens initiated coverage of Keel Infrastructure with an ‘Outperform’ rating and a price target of $10, implying an upside potential of 46% from current levels.<a href="https://stocktwits.com/symbol/KEEL">Keel shares</a> were up more than 4% in Wednesday’s pre-market trade after hitting a 52-week high on Tuesday.<h2 class="st-heading-2">Why Citizens Is Bullish On KEEL</h2>Citizens said Keel is capitalizing on a broader industry shift in which former bitcoin mining operators are repurposing existing power infrastructure to serve artificial intelligence and high-performance computing workloads.The firm noted that Keel's access to power capacity positions it to benefit from growing demand from hyperscale customers, which include some of the world's largest cloud and AI companies. As AI adoption accelerates, demand for data center capacity and reliable power has increased sharply, making existing power assets more valuable, Citizens said.The firm added that economic terms for providers of high-performance computing (HPC) infrastructure have improved significantly in recent years as customers compete to secure capacity.Citizens believes Keel is benefiting from the same market dynamics that have driven substantial outperformance among many of its peers over the past year, with demand for powered capacity continuing to rise as AI infrastructure buildouts expand.<h2 class="st-heading-2">KEEL Bolsters Balance Sheet With Convertible Notes Offering</h2>Earlier this month, Keel closed a $458 million offering of 1.25% convertible senior notes due 2032, generating approximately $445.4 million in net proceeds.The company said existing liquidity is already sufficient to advance its Panther Creek, Sharon and Moses Lake developments through the leasing phase. As a result, it expects the new capital to provide additional financial flexibility rather than fund near-term liquidity needs, allowing the company to pursue value-enhancing investments across its portfolio of digital infrastructure projects.Keel said the remaining proceeds will be used for general corporate purposes, including funding deposits for long-lead equipment and providing collateral for letters of credit tied to expanding or accelerating data center development projects.<h2 class="st-heading-2">What Retail Traders Think Of KEEL Stock</h2>Retail sentiment on Stocktwits around Keel trended in the ‘bullish’ territory, with message volumes at ‘high’ levels at the time of writing.<a href="https://stocktwits.com/symbol/KEEL">KEEL stock</a> is up 177% year-to-date and 784% over the past year. The Schwab U.S. Small-Cap ETF (SCHA) is up 40% over the past 12 months, while the iShares Morningstar Small-Cap Value ETF (ISCV) is up 26%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/spcx-bond-offering-attracts-3x-more-demand-outstanding-long-term-debt/cZKwBU1R7at">SPCX’s Inaugural Bond Offering Attracts Over 3x More Demand Than Its Outstanding Long-Term Debt: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of Keel Infrastructure Corp. in front of a screen in Shenzhen, Guangdong Province, China. (Photo illustration by Cheng Xin/Getty Images)

Shares of Keel Infrastructure Corp. (KEEL) are up more than 177% year-to-date, and Wall Street thinks the surge in the company’s shares is not done yet.

Keel Stock That's Up Over 8X In A Year Is Not Too Expensive Yet, According To One Analyst

iShares Morningstar Small-Cap Value ETF

Keel Infrastructure Corp

Schwab Strategic Trust - Schwab U.S. Small-Cap ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

ISCV iShares Morningstar Small-Cap Value ETF

Fundamentals

Latest ISCV News